Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Completed · Phase 3 · Has a placebo group
Conditions studied: Type 2 Diabetes
In brief
The primary objective of this study is to test the hypothesis that glycemic control, as measured by change in hemoglobin A1c (HbA1c) from baseline to endpoint, with exenatide is superior to that of placebo after 28 weeks of treatment in adolescent patients with type 2 diabetes who are naïve to antidiabetes agents, or patients who are being treated with metformin, an SU, or a combination of metformin and an SU
Key facts
- Study ID
- NCT00658021
- Run by
- AstraZeneca
- People needed
- 122
- Starts
- 2008-05-30
- Expected to finish
- 2020-04-01
- Last updated by the study team
- 2020-12-01
Who can join
Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Tucson, Arizona, United States
- Research Site — Los Angeles, California, United States
- Research Site — Montclair, California, United States
- Research Site — Sacramento, California, United States
- Research Site — San Diego, California, United States
- Research Site — Santa Ana, California, United States
- Research Site — Aurora, Colorado, United States
- Research Site — Melbourne, Florida, United States
- Research Site — Miami, Florida, United States
- Research Site — Miami Lakes, Florida, United States
- Research Site — Orlando, Florida, United States
- Research Site — Pensacola, Florida, United States
- Research Site — Tallahassee, Florida, United States
- Research Site — Dalton, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Wichita, Kansas, United States
- Research Site — Dearborn, Michigan, United States
- Research Site — Kansas City, Missouri, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Reno, Nevada, United States
- Research Site — Jamaica, New York, United States
- Research Site — Greenville, North Carolina, United States
- Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.